The FDA also said that death due to sepsis -- a severe inflammatory response triggered by infection -- following neutropenia has been reported in patients taking Onivyde.

Neutropenia, meaning a low white blood count accompanied by fever, is another immediate toxicity of some chemotherapy regimens that can be relatively straightforward to assess.

The study authors recommended that the neutropenia could be prevented with the blood stimulating factor, G-CSF.